Guillaume Cartron
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 102
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment 152
- Immunology top 0.5%
- Immune Cell Function and Interaction 23
- Oncology top 0.5%
- CAR-T cell therapy research 61
- Viral-associated cancers and disorders 27
-
- Monoclonal and Polyclonal Antibodies Research 54
-
- Multiple Myeloma Research and Treatments 16
-
- Protein Degradation and Inhibitors 15
Guillaume Cartron
257 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Genetics 2.8k
- Pathology and Forensic Medicine 3.6k
- Immunology 2.7k
- Oncology 3.3k
- Radiology, Nuclear Medicine and Imaging 2.5k
Countries citing papers authored by Guillaume Cartron
This map shows the geographic impact of Guillaume Cartron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume Cartron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume Cartron more than expected).
Fields of papers citing papers by Guillaume Cartron
This network shows the impact of papers produced by Guillaume Cartron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume Cartron. The network helps show where Guillaume Cartron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guillaume Cartron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 12 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 19 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 75 | |
| 14 | 2020 | 13 | |
| 15 | 2019 | 26 | |
| 16 | 2018 | 42 | |
| 17 | 2018 | 17 | |
| 18 | Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial. | 2015 | 18 |
| 19 | 2013 | 157 | |
| 20 | 2002 | 7 |
About Guillaume Cartron
Guillaume Cartron is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 268 papers that have together received 8.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (152 papers), Chronic Lymphocytic Leukemia Research (102 papers), CAR-T cell therapy research (61 papers), Monoclonal and Polyclonal Antibodies Research (54 papers), Viral-associated cancers and disorders (27 papers), Immune Cell Function and Interaction (23 papers), Multiple Myeloma Research and Treatments (16 papers) and Protein Degradation and Inhibitors (15 papers). The work is most often cited by research in Genetics (2.8k citations), Pathology and Forensic Medicine (3.6k citations) and Immunology (2.7k citations). Guillaume Cartron has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Hervé Watier, Philippe Solal‐Céligny, Gilles Salles, Philippe Colombat, P. Bardos, Laurent Dacheux, Franck Morschhauser, Josée Golay, Gilles Paintaud and Catherine Thiéblemont. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Haematologica and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.